Jul 22, 2026 06:52AM
Jun 30, 2026 07:30AM
Jun 30, 2026 07:30AM
Jun 29, 2026 07:30AM
Jun 29, 2026 07:30AM
Jun 22, 2026 07:30AM
Jun 22, 2026 07:30AM FDA Grants Rolling Review of Palvella’s QTORIN™ Rapamycin NDA for Microcystic Lymphatic Malformations
Jun 9, 2026 08:43AM
Jun 9, 2026 08:43AM
Jun 3, 2026 07:30AM
Jun 3, 2026 07:30AM
Jun 2, 2026 07:30AM
May 27, 2026 07:31AM
May 27, 2026 07:30AM Palvella Therapeutics Strengthens QTORIN™ Pitavastatin Intellectual Property with Yale-Licensed U.S. Patent Providing Protection into 2043
May 21, 2026 07:30AM
May 20, 2026 04:30PM
May 20, 2026 04:30PM
May 15, 2026 07:30AM
May 15, 2026 07:30AM
May 15, 2026 07:30AM
May 13, 2026 07:30AM Palvella Therapeutics moves to NASDAQ Global Market
May 13, 2026 07:30AM
May 12, 2026 02:54AM
May 7, 2026 07:30AM
May 4, 2026 07:30AM
May 4, 2026 07:30AM
Apr 30, 2026 07:30AM
Apr 20, 2026 07:30AM Palvella to present QTORIN rapamycin study results at vascular congress
Apr 20, 2026 07:30AM
Apr 13, 2026 07:30AM
Apr 13, 2026 07:30AM
Apr 7, 2026 12:26PM
Apr 7, 2026 07:30AM
Mar 31, 2026 03:06PM
Mar 31, 2026 07:30AM Palvella Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update
Mar 30, 2026 07:31AM
Mar 30, 2026 07:30AM
Mar 27, 2026 10:30AM
Mar 27, 2026 10:30AM
Mar 24, 2026 09:50AM
Mar 24, 2026 07:30AM
Mar 23, 2026 07:30AM Palvella hires Jennifer McDonough as market access VP
Mar 23, 2026 07:30AM
Mar 23, 2026 07:30AM
Mar 16, 2026 07:31AM
Mar 16, 2026 07:30AM
Mar 10, 2026 12:23PM
Mar 10, 2026 07:31AM
Mar 10, 2026 07:30AM Palvella Therapeutics Launches "BEYOND mLM" Disease Awareness Campaign for Microcystic Lymphatic Malformations in Collaboration with Leading Lymphatic, Vascular, and Dermatology Nonprofit Or
Mar 2, 2026 07:30AM

326,253 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All